ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
AstraZeneca
AstraZeneca
Origin Sciences
National Institutes of Health Clinical Center (CC)
UMC Utrecht
AstraZeneca
Alliance for Clinical Trials in Oncology
University of Nebraska
Adela, Inc
Elephas
Elephas
Washington University School of Medicine
University of Texas Southwestern Medical Center
Travera Inc
Guardant Health, Inc.
Tempus AI
Arbeitsgemeinschaft medikamentoese Tumortherapie
Royal Marsden NHS Foundation Trust
Singlera Genomics Inc.
Travera Inc
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Cancer Support Community, Research and Training Institute, Philadelphia
University of California, Davis
University Hospital, Tours
Memorial Sloan Kettering Cancer Center
Wuhan Ammunition Life-tech Co., Ltd
Exact Sciences Corporation
Assistance Publique - Hôpitaux de Paris
TScan Therapeutics, Inc.
SpeciCare
Gary Onik MD
Swiss Cancer Institute
CureOne
Quantgene Inc.
Alliance for Clinical Trials in Oncology
GlaxoSmithKline
Wake Forest University Health Sciences
Università degli Studi 'G. d'Annunzio' Chieti e Pescara
Amgen
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
AHS Cancer Control Alberta
OHSU Knight Cancer Institute
Sandoz
Meir Medical Center